Cargando…
Controlling the thickness of the atherosclerotic plaque by statin medication
Atherosclerosis, a chronic inflammatory disorder of the arterial wall, is a complex process whose dynamics are affected by multiple factors. The disease control consists of restraining it by administering statins. Slowing down or halting the plaque growth depends on the patient age at which the stat...
Autores principales: | Formanowicz, Dorota, Krawczyk, Jacek B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553348/ https://www.ncbi.nlm.nih.gov/pubmed/33048950 http://dx.doi.org/10.1371/journal.pone.0239953 |
Ejemplares similares
-
Management of High-Risk Atherosclerotic Patients by Statins May Be Supported by Logistic Model of Intima-Media Thickening
por: Formanowicz, Dorota, et al.
Publicado: (2021) -
Statin effects on atherosclerotic plaques: regression or healing?
por: Bittencourt, Marcio Sommer, et al.
Publicado: (2015) -
A Control-Theoretic Model of Atherosclerosis
por: Formanowicz, Dorota, et al.
Publicado: (2019) -
Statin/ezetimibe combination therapy vs statin monotherapy for carotid atherosclerotic plaque inflammation
por: Oh, Minyoung, et al.
Publicado: (2021) -
Statin Treatment, Carotid Atherosclerotic Plaque Macrophage Infiltration and Circulating Inflammatory Markers
por: Koutouzis, Michael, et al.
Publicado: (2008)